Dushanbe, Tajikistan, April 4, 2022 — With today’s delivery of 198,900 doses of the Pfizer vaccine, the United States — through the United States Agency for International Development (USAID) — has donated more than 2.8 million doses of Pfizer and Moderna vaccines to Tajikistan. These deliveries have been made possible through COVAX, a global initiative to support equitable access to COVID-19 vaccines.
Since March 2020, the United States has provided more than $13.5 million in equipment and technical support to help the Tajikistan fight against COVID-19. This support has been used to procure medical supplies and personal protective equipment, upgrade laboratories, train public health and medical professionals as well as support vaccination efforts in Tajikistan. The United States will continue partnering with Tajikistan to end the COVID-19 pandemic, mitigate its devastating social and economic impacts and improve preparedness to respond to future outbreaks.
To accelerate the global fight against COVID-19 and reinforce the United States’ ongoing efforts to get more shots in arms, the U.S. government has donated more than 1.2 billion of the COVID-19 vaccines to the countries most in need — safely, equitably, and with no strings attached. To date, USAID has provided $5.7 billion to provide vaccines worldwide, with more on the way.
Noting the success of Tajikistan’s vaccine campaign that has already reached more than 88 percent of the target population, the USAID Acting Mission Director for Tajikistan James Parys said, “We are committed to ensuring Tajikistan reaches 70 percent full vaccination coverage by next September under the Biden Administration’s initiative “to vaccinate the world.”
USAID is the world’s premier international development agency and a catalytic actor driving development results. For more information, visit: https://www.usaid.gov/tajikistan and Facebook page: https://www.facebook.com/usembassy.duahanbe
